12 promising life sciences startups are selected for FAST California accelerator program


September 20, 2023

SAN FRANCISCO, SAN DIEGO, LOS ANGELES, SACRAMENTO, Calif. – A dozen life sciences startups have been selected to receive 12 weeks of business mentoring from expert advisors through California Life Sciences’ (CLS) program, FAST California.

Now in its tenth year, FAST supports founders of disruptive and innovative life sciences startups. The 12 companies were selected by an expert panel from more than 60 applicants and is our most diverse group of founders to date. They are advancing solutions to health problems like cancer, auto-immune diseases, hearing loss, and more:


Senseer Health | Pasadena, CA
Palm Therapeutics | San Diego, CA
EV Therapeutics | San Francisco, CA
Aluda Pharmaceuticals | Menlo Park, CA
BIOMED | Marina Del Rey, CA
BioSuperior Technology | Los Altos, CA
TIGAR Health Technologies | Moraga, CA
ImmunoWork | Monrovia, CA
Origami Therapeutics | San Diego, CA
Jacaranda Biosciences | San Francisco, CA
BioDrive | Alameda, CA
Endure Biotherapeutics | San Diego, CA


Each company will be matched with a group of advisors to perfect their business models, assess strategic focus, maximize IP, and help develop a milestone and scale-up plan to exit. FAST California is offered at no cost and no equity is taken.

“California Life Sciences is committed to empowering the life sciences community to deliver innovative solutions for patients. One of the many ways we do this is by supporting cutting edge science and innovators through FAST California. More than 120 startups have graduated our program, and we’re excited to see some of our FAST graduates like Shasqi, SyntheX, and Valitor, accomplish important milestones,” said Shikha Sharma, senior director of Innovation & Entrepreneurship.

The Fall 2023 cycle will conclude with an Innovation Showcase on December 12 in San Francisco, where the founders will pitch to an audience of potential investors and collaboration partners.

About California Life Sciences: California Life Sciences (CLS) is the state’s most influential and impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. With offices in South San Francisco, San Diego, Sacramento, Los Angeles, and Washington DC, CLS works to shape public policy, improve access to breakthrough technologies, educate lawmakers, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. In doing so, CLS fulfills its mission to protect and nurture California’s life sciences industry, empowering discoveries that lead to healthier lives around the world.